The Association of Real-World CA 19-9 Level Monitoring Patterns and Clinical Outcomes Among Patients With Metastatic Pancreatic Ductal Adenocarcinoma

BACKGROUND: Pancreatic cancer is expected to be the third deadliest cancer in the US in 2021. Evaluation of treatment response in patients with mPDAC necessitates scheduled clinical and radiographic assessments along with monitoring serum CA 19-9 levels. Currently available single-institution data e...

Descripción completa

Detalles Bibliográficos
Autores principales: George, Ben, Kent, Matthew, Surinach, Andy, Lamarre, Neil, Cockrum, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522478/
https://www.ncbi.nlm.nih.gov/pubmed/34671563
http://dx.doi.org/10.3389/fonc.2021.754687

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8522478/
https://www.ncbi.nlm.nih.gov/pubmed/34671563
http://dx.doi.org/10.3389/fonc.2021.754687

Ejemplares similares